3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thymic aplasia
1
Polycythemia Vera
1
Myeloproliferative Disorders
1
Immunologic Deficiency Syndromes
1
Interventions
nilotinib
1
fludarabine phosphate
1
fludarabine
1
bosutinib
1
asciminib
1
Phlebotomy
1
Imatinib Mesylate
1
Dasatinib
1
Busulfan
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Myeloproliferative Disorders
×
Phlebotomy
×
Clear all
NCT06290765
2025-07-31
PV
PharmaEssentia
Phase 4
Not yet recruiting
70 enrolled